Login / Signup

Variation in prostate cancer treatment and spending among Medicare shared savings program accountable care organizations.

Parth K ModiSamuel R KaufmanTudor BorzaPhyllis YanDavid C MillerTed A SkolarusJohn M HollingsworthEdward C NortonVahakn B ShahinianBrent K Hollenbeck
Published in: Cancer (2018)
ACOs vary widely in treatment, potential overtreatment, and spending for prostate cancer. ACOs with stronger urologist engagement are less likely to treat men with a high risk of noncancer mortality, and this suggests that organizations that better engage specialists may be able to improve the value of specialty care. Cancer 2018. © 2018 American Cancer Society.
Keyphrases